Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase
详细信息 查看全文
- 作者：Michael E. Prime ; Stephen M. Courtney ; Frederick A. Brookfield ; Richard W. Marston ; Victoria Walker ; Justin Warne ; Andrew E. Boyd ; Norman A. Kairies ; Wolfgang von der Saal ; Anja Limberg ; Guy Georges ; Richard A. Engh ; Bernhard Goller ; Petra Rueger ; Matthias Rueth
- 刊名：Journal of Medicinal Chemistry
- 出版年：2011
- 出版时间：January 13, 2011
- 年：2011
- 卷：54
- 期：1
- 页码：312-319
- 全文大小：922K
- 年卷期：v.54,no.1(January 13, 2011)
- ISSN：1520-4804
文摘
The inhibition of Aurora kinases in order to arrest mitosis and subsequently inhibit tumor growth via apoptosis of proliferating cells has generated significant discussion within the literature. We report a novel class of Aurora kinase inhibitors based upon a phthalazinone pyrazole scaffold. The development of the phthalazinone template resulted in a potent Aurora-A selective series of compounds (typically >1000-fold selectivity over Aurora-B) that display good pharmacological profiles with significantly improved oral bioavailability compared to the well studied Aurora inhibitor VX-680.